Sponsors (69)
I'll give you the short version of this bill.
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Read twice and referred to the Committee on Finance.
Introduced January 30, 2025 by Michael Dean Crapo · Last progress January 30, 2025
Creates a Medicare coverage pathway for "multi-cancer early detection" (MCED) screening tests, defines which tests qualify, and sets rules for how Medicare will pay for them. Tests must be furnished on or after January 1, 2028 to meet the new definition; payment methodology and limits change again on January 1, 2031.
Coverage decisions must follow the existing national coverage determination (NCD) process, and certain U.S. Preventive Services Task Force (USPSTF) recommendations can override subsection limits. The measure updates related Medicare rules to implement definition, coverage, payment, and claims administration for MCED tests.
Adds multi-cancer early detection screening tests to the definitions in section 1861 by inserting a new subparagraph in subsection (s)(2) and by adding a new subsection (nnn) that defines 'multi-cancer early detection screening test' and requires use of the National Coverage Determination process for coverage determinations.
Adds a new subsection (aa) to section 1834 establishing payment amount rules, frequency/age limitations, and standards for multi-cancer early detection screening tests, and sets a special rule when a USPSTF A/B recommendation applies.
Updates cross-references in section 1833 to include the newly added subsection (aa) of section 1834 where previously only subsection (d)(1) of section 1834 was referenced.
Adds a new exclusion (subparagraph (Q)) in section 1862(a)(1) for multi-cancer early detection screening tests that are not reasonable and necessary for concurrent detection of multiple cancer types, and updates paragraph (7) to reference the new exclusion.
Read twice and referred to the Committee on Finance.
Introduced in Senate
